P

Inventor

GIBSON CHRISTOPH

DE10 patents
⚠️ This page may combine multiple inventors who share the name “GIBSON CHRISTOPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PHARVARIS NETHERLANDS B V

3 patents
US11820756B2Nov 21, 2023

Bradykinin B2 receptor antagonists

PHARVARIS NETHERLANDS B V1 citations67
US11261173B2Mar 1, 2022

Bradykinin B2 receptor antagonists

PHARVARIS NETHERLANDS B V1 citations67
US10836748B2Nov 17, 2020

Bradykinin B2 receptor antagonists

PHARVARIS NETHERLANDS B V2 citations67

MERCK PATENT GMBH

2 patents
US6326403B1Dec 4, 2001

Diacylhydrazine derivatives as integrin inhibitors

MERCK PATENT GMBH49 citations90
US6649613B1Nov 18, 2003

Diacylhydrazine derivatives

MERCK PATENT GMBH11 citations72

BIOMET DEUTSCHLAND GMBH

2 patents
US7655624B2Feb 2, 2010

Peptide and peptide mimetic conjugates with integrin-inhibitor properties

BIOMET DEUTSCHLAND GMBH12 citations82
US7276482B2Oct 2, 2007

Peptide and peptide mimetic derivatives with integrin-inhibitors properties II

BIOMET DEUTSCHLAND GMBH1 citations50

PHARVARIS GMBH

2 patents
US12391681B2Aug 19, 2025

(R)-3-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)morpholine derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases

PHARVARIS GMBH0 citations42
US12312330B2May 27, 2025

1-((S)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)ethyl)-imidazolidine-2,4-dione derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseases

PHARVARIS GMBH0 citations42

GIBSON CHRISTOPH

1 patent
US8410134B2Apr 2, 2013

8-oxy-quinoline derivatives as bradykinin B2 receptor modulators

GIBSON CHRISTOPH1 citations41